PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25159192 ↗2014Reported benefit

Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model.

MouseRadiationAthymic nudeIntraperitonealSchedules included dosing before irradiation and a post-irradiation only schedu…

Model: Single large dose of ionising radiation delivered to a 4 square centimetre area of flank skin (30 or 40 Gy)

Vasculotide reduced the size of the irradiation-induced wound and overall skin damage, lowered oxygenated haemoglobin, myeloperoxidase bioluminescence and MIP-2, increased microvascular endothelial cell density in granulation tissue and enhanced endothelial survival and function in vitro, without a…

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.